Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Interaction Map Network Comparison Type Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1 to 50 of 16578 in total 
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase d precursor (ec 3.4.17.-) (gp180). [source:swissprot;acc:o75976]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
107\vspace{3pt}}}\\\cline{2-3}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 1 precursor (lamp-1) (cd107a antigen). [source:swissprot;acc:p11279]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.4\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 4 (ec 2.7.1.37) (cyclin-dependent kinase 4) (psk-j3). [source:swissprot;acc:p11802]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
107\vspace{3pt}}}\\\cline{2-3}\cline{5-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 1 precursor (lamp-1) (cd107a antigen). [source:swissprot;acc:p11279]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 4 (ec 2.7.1.37) (cyclin-dependent kinase 4) (psk-j3). [source:swissprot;acc:p11802]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{7-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 6 (ec 2.7.1.37) (serine/threonine protein kinase plstire). [source:swissprot;acc:q00534]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcG}{\vspace{3pt}\noindent
107\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
105\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 6 (ec 2.7.1.37) (serine/threonine protein kinase plstire). [source:swissprot;acc:q00534]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 2 precursor (lamp-2) (cd107b antigen). [source:swissprot;acc:p13473]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
107\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
105\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 2 precursor (lamp-2) (cd107b antigen). [source:swissprot;acc:p13473]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
330\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.47982\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 6 (osbp-related protein 6) (orp-6). [source:swissprot;acc:q9bzf3]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
78\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
97\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.86667\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 3 (osbp-related protein 3) (orp-3). [source:swissprot;acc:q9h4l5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
240\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
78\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{7-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 6 (osbp-related protein 6) (orp-6). [source:swissprot;acc:q9bzf3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcG}{\vspace{3pt}\noindent
1.325\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
97\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.49767\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 3 (osbp-related protein 3) (orp-3). [source:swissprot;acc:q9h4l5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
240\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.325\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{7-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 7 (osbp-related protein 7) (orp-7). [source:swissprot;acc:q9bzf2]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcG}{\vspace{3pt}\noindent
78\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
288.754\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
212.554\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
76.2\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
322\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.49767\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
74\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 7 (osbp-related protein 7) (orp-7). [source:swissprot;acc:q9bzf2]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.325\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
247.246\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
58.226\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
247.213\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
58.186\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
74\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.45755\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
247.169\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
58.134\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.31818\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
309\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.45755\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
74\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bestrophin (vitelliform macular dystrophy protein) (tu15b). [source:swissprot;acc:o76090]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28.4944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.30966\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
74\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.45259\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
304.548\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
246.824\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
57.724\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
266.856\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.233\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.377\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.45259\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
304.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
246.737\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
57.622\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 2. [source:refseq;acc:nm\_153274]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.3475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28.5242\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.30933\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.856\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
336.233\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
69.377\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
37.9984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
29.1831\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.30207\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/